从肝脏脂肪到全面代谢紊乱:肾脏为靶器官

IF 3.9

Metabolism and target organ damage Pub Date : 2022-01-01 DOI:10.20517/mtod.2022.17

M. Petroni, G. Marchesini

{"title":"从肝脏脂肪到全面代谢紊乱:肾脏为靶器官","authors":"M. Petroni, G. Marchesini","doi":"10.20517/mtod.2022.17","DOIUrl":null,"url":null,"abstract":"study of subjects classified as advanced fibrosis by biomarker [high nonalcoholic fibrosis score (NFD) vs. low NFD; HR, 1.59], as well as in two studies where liver biopsy was available (fibrosis ≥ F3 vs. fibrosis < F3; HR, 2.75 and 3.25, respectively). The authors concluded that an effect of disease severity is very likely, but data are needed to support this evidence.","PeriodicalId":91001,"journal":{"name":"Metabolism and target organ damage","volume":"1 1","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"From liver fat to full-blown metabolic disorder: the kidney as target organ\",\"authors\":\"M. Petroni, G. Marchesini\",\"doi\":\"10.20517/mtod.2022.17\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"study of subjects classified as advanced fibrosis by biomarker [high nonalcoholic fibrosis score (NFD) vs. low NFD; HR, 1.59], as well as in two studies where liver biopsy was available (fibrosis ≥ F3 vs. fibrosis < F3; HR, 2.75 and 3.25, respectively). The authors concluded that an effect of disease severity is very likely, but data are needed to support this evidence.\",\"PeriodicalId\":91001,\"journal\":{\"name\":\"Metabolism and target organ damage\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Metabolism and target organ damage\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20517/mtod.2022.17\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolism and target organ damage","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20517/mtod.2022.17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

根据生物标志物分类为晚期纤维化的受试者的研究[高非酒精性纤维化评分(NFD) vs低NFD;HR, 1.59]，以及两项可进行肝活检的研究(纤维化≥F3 vs纤维化< F3;HR分别为2.75和3.25)。作者得出结论，疾病严重程度的影响是很可能的，但需要数据来支持这一证据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

From liver fat to full-blown metabolic disorder: the kidney as target organ

study of subjects classified as advanced fibrosis by biomarker [high nonalcoholic fibrosis score (NFD) vs. low NFD; HR, 1.59], as well as in two studies where liver biopsy was available (fibrosis ≥ F3 vs. fibrosis < F3; HR, 2.75 and 3.25, respectively). The authors concluded that an effect of disease severity is very likely, but data are needed to support this evidence.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Metabolism and target organ damage

CiteScore

3.00

自引率

0.00%

发文量